Wilmer Cutler Pickering Hale and Dorr represented Beam Therapeutics Inc., and Davis Polk & Wardwell advised the underwriters in the offering. Beam Therapeutics Inc. (Nasdaq: BEAM)...
Beam Therapeutics’ $500 Million Common Stock Offering
RenaissanceRe Holdings Ltd.’s $500 Million Senior Notes Offering
Sidley Austin advised RenaissanceRe Holdings and Carey Olsen Bermuda Limited advised the company under Bermuda laws, and Debevoise & Plimpton advised the underwriters on the offering....
Flowco’s $491.3 Million IPO
Sidley Austin represented Flowco Holdings Inc. in the offering, and Latham & Watkins represented the underwriters. Flowco Holdings Inc. (Flowco) announced its initial public offering of...
Disc Medicine’s $259.3 Million Follow-on Offering
Goodwin Procter advised Disc Medicine, while Wilmer Cutler Pickering Hale and Dorr advised the underwriters on the offering. Disc Medicine (NASDAQ: IRON) announced its upsized underwritten...
Jefferies Finance’s $1.95 Billion Bank and Bond Financing
Sidley Austin represented Jefferies Finance LLC in the transaction. Jefferies Finance LLC, as borrower and issuer, announced its US$1.95 billion bank/bond financing, consisting of a US$950...
BioAge Labs’ $238 Million Upsized Initial Public Offering
Fenwick & West represented BioAge Labs, Inc. in the offering, and Cooley represented the underwriters. BioAge Labs, Inc. (Nasdaq: BIOA), a clinical-stage biopharmaceutical company developing therapeutic...
New Fortress Energy’s $400 Million Common Stock Offering
Skadden, Arps, Slate, Meagher & Flom represented New Fortress Energy Inc. in the offering, and Vinson & Elkins represented the underwriters. New Fortress Energy Inc. (Nasdaq:...
InvenTrust Properties Corp.’s $224 Million Common Stock Offering
Latham & Watkins advised InvenTrust Properties Corp. on the offering, Venable acted as counsel to the company under Maryland law and Hunton Andrews Kurth advised the...
MBX Biosciences’ $187.7 Million IPO
Goodwin Procter and Wilson Sonsini Goodrich & Rosati represented MBX Biosciences, Inc. in the offering, and Davis Polk & Wardwell represented the underwriters. MBX Biosciences, Inc....
Viridian Therapeutics’ $258.8 Million Follow-on Public Offering
Ropes & Gray represented Viridian Therapeutics, Inc. in the offering, and Wilmer Cutler Pickering Hale and Dorr represented the underwriters. Viridian Therapeutics, Inc. (Nasdaq: VRDN), a...
Terns Pharmaceuticals’ $172.7 Million IPO
Wilmer Cutler Pickering Hale and Dorr and Cooley advised on Terns Pharmaceuticals, Inc. on the offering, and Davis Polk & Wardwell advised the underwriters. Terns Pharmaceuticals,...
Foghorn Therapeutics’ $110 Million Common Stock Offering
Ropes & Gray advised Foghorn Therapeutics Inc. on the offering, and Latham & Watkins advised the underwriters. Foghorn Therapeutics Inc. (Nasdaq: FHTX) (“Foghorn”), a clinical-stage biotechnology...